INTRODUCTION
Non-steroidal anti-inflammatory drugs (NSAIDs) are most commonly used drugs for years for management of pain and inflammation with good efficacy and represent most widely prescribed class of medications in the world and are used as over the counter drugs (OTC).
1 NSAIDS inhibit cyclooxygenase (COX) enzymes which catalyse the metabolism of arachidonic acid into prostaglandins. COX is available in two isoforms i.e. COX-1 and COX-2.
2, 3 The COX-1 enzyme is constitutive in nature involved in generating prostaglandins for physiological function like gastric mucosal protection, regulation of renal blood flow and platelet homeostasis, while COX-2 has been termed as an inducible enzymes involved in inflammation, colorectal cancer and neurodegenerative disorders. 4 A new isoform COX-3 has been recently discovered, although its role is yet not clear. 5 Despite wide clinical use of classical NSAIDs as analgesics, anti-pyretics, and anti-inflammatory agents their gastro-intestinal toxicity (dyspepsia, peptic ulcers and gastrointestinal bleeds) is a major clinical limitation. 6 Selective COX-2 inhibitors were developed with the aim of minimizing gastrointestinal toxicity, while maintaining anti-inflammatory activity. 7 However, clinical and experimental data, as well as reviews suggest that the long term use of selective COX-2 inhibitors is associated with an increase in systolic blood pressure and cardiovascular morbidity and mortality due to myocardial infarction. 8, 9 The use of NSAIDs is an important predisposing factor for peptic ulcer disease in the community. Approximately 10-20% of patients who receive long-term NSAID therapy develop asymptomatic peptic ulceration and ulcer-related complications (bleeding and perforation) develop in 1-2% of persons per year. 10 This warrants a cautious use of NSAIDs in high risk individuals who include the elderly, those already receiving gastro-toxic agents and those with a history of gastro-intestinal diseases.
11 So, the best alternative in such individuals would be the co-administration of NSAIDs with gastroprotective drugs. Misoprostol, an analog of prostaglandin E1, has been specifically approved for the prevention of NSAID-induced ulcers in high-risk patients. 12, 13 Proton pump inhibitors too, have been used with outstanding efficacy for this indication.
Drug utilization studies are continuing programmes that review, analyze and interpret the pattern of drug use against pre-determined standards. This drug utilization study was conducted to study the co-administration of non-steroidal anti-inflammatory drugs (NSAIDs) with gastroprotective drugs in an orthopaedics outpatient unit of an urban, tertiary care, teaching hospital. We selected orthopaedics outpatient unit because of frequently prescribed NSAIDs in this department for the management of pain and inflammation.
METHODS

Ethical considerations:
The study protocol, informed consent form (in Bengali, Hindi & English) and case report form (CRF) were submitted to the ethics committee of College of Medicine & JNM Hospital, Kalyani, Nadia, West Bengal for approval. Subject recruitment commenced only after approval was obtained. Written informed consent was taken from each participant. Illiterate individuals gave their fingerprint (left thumb impression) instead of signature in the presence of an appropriate witness.
Subject selection criteria:
The subjects who had willingly participated were enrolled on the basis of inclusion and exclusion criteria. All the patients using NSAIDs with or without gastroprotective agents, between 18-60 years of age, irrespective of sex, were studied. However, patients who were pregnant, lactating, unable to comply due to mental retardation, unconsciousness or drug addiction were excluded from the study. 
Study population:
The present study was conducted on 977 patients who visited the orthopaedics outpatient unit during the 6-month period.
Study methodology:
A cross sectional, unicentric study was conducted in the orthopaedics outpatient department of an urban, tertiary care, medical college hospital in West Bengal during April 2012 to September 2012. Prescriptions were collected from patients attending the orthopaedics outpatients department. The prescription pattern of NSAIDs, gastroprotective agents or coadministration of NSAIDs and gastroprotective agents were analyzed. No follow up of prescription was done.
RESULTS
In a six months period from April 2012 to September 2012, a total of 977 patients were included in the study and their prescriptions were analyzed only once-no follow up visit was done.
The demographic profiles have been described in Table  1 . None of the other gastroprotective agents were used. The different drugs used in these groups are shown in Table 2 .
The use of gastroprotective agents along with the seven commonly used NSAIDs, either as monotherapy or Fixed Drug Combinations (FDC), is shown in Table 3 .
The generic prescription of NSAIDs with or without gastroprotective agents are shown in Table 4 . Among the drugs, ibuprofen, paracetamol, diclofenac, famotidine, and ranitidine were prescribed in generic form.
DISCUSSION
When gastric side effects are a cause of concern, non selective COX inhibitors are co-prescribed with an antiulcer agent. The use of selective COX-2 inhibitors seems to have decreased after the cardiac adverse effects which were observed with these drugs. 8, 9 Diclofenac+PCM+Chlorzoxazone, Etoricoxib, Lornoxicam, Piroxicam, PCM+Tramadol were most commonly co-prescribed NSAIDS with a gastroprotective agent-100%. Ibuprofen was the second most commonly used NSAIDS with a gastroprotective agent-97.92%. PPIs produce more sustained acid suppression as compared to H 2 antagonists and promote ulcer healing despite continued NSAIDS therapy.
14,15 But in this study, H 2 antagonists were the most commonly used gastroprotective agents, followed by proton pump inhibitors. The cause may be due to freely available of H 2 antagonists in the hospital pharmacy, it was prescribed more frequently. Antacids were used in least although it was also freely available in hospital. But due to less effective than PPIs and H 2 antagonists it was prescribed in fewer amounts. Antacids are indicated only for symptomatic relief of pain and are associated with a number of drug interactions, thereby restricting their use. 11 Misoprostol, the drug indicated for the prophylaxis of high risk individuals, were not used at all. This may be because of various reasons including the higher cost, frequent side effects and the need for multiple daily dosing of Misoprostol. In any case, similar or even better efficacy is obtained by proton pump inhibitors in preventing and/or treating NSAID-induced peptic ulcers. 16, 17 There was no prescription of sucralfate as gastroprotective agents.
The drugs like Ibuprofen, Paracetamol (PCM), Diclofenac, Famotidine and Ranitidine that were supplied in hospital at free of cost, were prescribed in generic form in 100% cases but the other drugs were not prescribed generically in such high percentage. 
CONCLUSION
To conclude, our study shows that nonselective COX inhibitors more commonly preferred analgesics than COX-2 inhibitors. NSAIDs were commonly co-prescribed with gastroprotective agents in a high percentage, and H 2 blockers are the most common gastroprotective agents used simultaneously with NSAIDs.
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